Recent Patents on Anti-Cancer Drug Discovery

Khurshid Zaman  
Bentham Science Publishers
USA

Back

Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents

Volume:2   Issue:2
Pp: 119-134
Alfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, Monia Rocco, Giuseppe Manzo and Michele Caraglia
DOI: 10.2174/157489207780832450

Order Reprints Order Eprints

Integrin αvβ3 Antagonists for Anti-Angiogenic Cancer Treatment

Volume:2   Issue:2
Pp: 143-158
Andrew R. Hsu, Anand Veeravagu, Weibo Cai, Lewis C. Hou, Victor Tse and Xiaoyuan Chen
DOI: 10.2174/157489207780832469

Order Reprints Order Eprints

Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors

Volume:2   Issue:2
Pp: 159-166
Barbara J. Kelly, Marina N. Fleeton and Gregory J. Atkins
DOI: 10.2174/157489207780832432

Order Reprints Order Eprints

Thalidomide Analogues as Anticancer Drugs

Volume:2   Issue:2
Pp: 167-174
Jeanny B. Aragon-Ching, Haiqing Li, Erin R. Gardner and William D. Figg
DOI: 10.2174/157489207780832478

Order Reprints Order Eprints

Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer

Volume:2   Issue:2
Pp: 175-186
Constantinos Mikelis, Marina Koutsioumpa and Evangelia Papadimitriou
DOI: 10.2174/157489207780832405

Order Reprints Order Eprints

Patent Selections promotion: free to download

Volume:2   Issue:2
Pp: 187-188
Bentham Science Publishers
DOI: 10.2174/157489207780832441

Order Reprints Order Eprints